Keebeck Wealth Management, LLC Abb Vie Inc. Transaction History

Keebeck Wealth Management, LLC

$670 Million
Q4 2024

A detailed history of Keebeck Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 25,008 shares of ABBV stock, worth $4.82 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

25,008

Previous 25,149 0.56%

Holding current value

$4.82 Million

Previous $4.97 Million 10.53%

% of portfolio

0.66%

Previous 0.74%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $23,263 - $28,745	-141 Reduced 0.56%	25,008 $4.44 Million
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $38,338 - $46,643	-234 Reduced 0.92%	25,149 $4.97 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $1.35 Million - $1.57 Million	8,711 Added 52.25%	25,383 $4.35 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $2.14 Million - $2.44 Million	13,380 Added 406.44%	16,672 $3.04 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $10,595 - $11,932	77 Added 2.4%	3,292 $510,000
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $22,443 - $25,981	168 Added 5.51%	3,215 $479,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $4,637 - $5,771	35 Added 1.16%	3,047 $410,000
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $103,540 - $119,242	-716 Reduced 19.21%	3,012 $480,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $3,042 - $3,649	22 Added 0.59%	3,728 $602,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1,073 - $1,231	8 Added 0.22%	3,706 $497,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $963 - $1,224	7 Added 0.19%	3,698 $566,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $1,055 - $1,310	8 Added 0.22%	3,691 $598,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $33,518 - $42,410	312 Added 9.26%	3,683 $499,000
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $851 - $966	8 Added 0.24%	3,371 $364,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $1.78 Million - $1.98 Million	-16,896 Reduced 83.4%	3,363 $379,000
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $11,662 - $12,838	-114 Reduced 0.56%	20,259 $2.19 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $885 - $1,195	11 Added 0.05%	20,373 $2.18 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $77,662 - $91,150	904 Added 4.65%	20,362 $1.78 Million
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $1.43 Million - $1.91 Million	19,458 New	19,458 $1.91 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $158,541 - $240,367	-2,458 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $177,295 - $221,834	2,458 New	2,458 $217,000

Others Institutions Holding ABBV

# of Institutions

4,078

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.1M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.

Account

Keebeck Wealth Management, LLC Abb Vie Inc. Transaction History